Kyung-Sang Yu


Ontology type: schema:Person     


Person Info

NAME

Kyung-Sang

SURNAME

Yu

Publications in SciGraph latest 50 shown

  • 2022-05-05 Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension in SCIENTIFIC REPORTS
  • 2021-03-18 Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy in SCIENTIFIC REPORTS
  • 2020-05-27 Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers in THE PHARMACOGENOMICS JOURNAL
  • 2019-12-19 Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects in SCIENTIFIC REPORTS
  • 2019-11-13 Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction in SCIENTIFIC REPORTS
  • 2019-08-28 Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing in BONE MARROW TRANSPLANTATION
  • 2019-02-27 Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways in METABOLOMICS
  • 2018-10-15 Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug–Drug Interaction Potentials in PHARMACEUTICAL RESEARCH
  • 2018-08-08 Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction in SCIENTIFIC REPORTS
  • 2018-06-18 Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients in BONE MARROW TRANSPLANTATION
  • 2018-06-15 Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2017-05-27 LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects in BIODRUGS
  • 2017-05-23 Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations in EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
  • 2017-05-18 Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females in THE AAPS JOURNAL
  • 2017-05-10 Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients in SCIENTIFIC REPORTS
  • 2017-02-03 Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male Volunteers in CLINICAL DRUG INVESTIGATION
  • 2016-11-02 Reliable prediction of anti-diabetic drug failure using a reject option in PATTERN ANALYSIS AND APPLICATIONS
  • 2016-06-17 Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach in THE AAPS JOURNAL
  • 2015-05-29 Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in CLINICAL DRUG INVESTIGATION
  • 2015-01-30 Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway in SCIENTIFIC REPORTS
  • 2014-06-07 Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects in AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
  • 2014-05-07 Tolerability and Pharmacokinetics of Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, After a Single Oral Administration in Healthy Female Subjects in CLINICAL DRUG INVESTIGATION
  • 2014-04-02 The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects in DRUGS IN R&D
  • 2014-03-17 Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug in BMC NEPHROLOGY
  • 2014-03-14 Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects in CLINICAL DRUG INVESTIGATION
  • 2014-03-13 Pharmacodynamics, Pharmacokinetics, and Tolerability of Intravenous or Subcutaneous GC1113, a Novel Erythropoiesis-Stimulating Agent in CLINICAL DRUG INVESTIGATION
  • 2014-02-24 Aspirin Decreases Systemic Exposure to Clopidogrel Through Modulation of P‐Glycoprotein But Does Not Alter Its Antithrombotic Activity in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2014-01-28 An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects in INVESTIGATIONAL NEW DRUGS
  • 2013-09-28 Relationship Between Absolute Neutrophil Count Profiles and Pharmacokinetics of DA-3031, a Pegylated Granulocyte Colony-Stimulating Factor (Pegylated-G-CSF): A Dose Block-Randomized, Double-Blind, Dose-Escalation Study in Healthy Subjects in CLINICAL DRUG INVESTIGATION
  • 2013-06-19 Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2013-01-29 Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers in BIODRUGS
  • 2012-10-02 Comparative Pharmacokinetics/Pharmacodynamics of Clopidogrel Besylate and Clopidogrel Bisulfate in Healthy Korean Subjects in CLINICAL DRUG INVESTIGATION
  • 2012-09 Compartmental modeling and simplified quantification of [11C]sertraline distribution in human brain in ARCHIVES OF PHARMACAL RESEARCH
  • 2012-06 Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel ®) in BIODRUGS
  • 2012-04-13 Quantitative and Qualitative Analysis of CKD-501, Lobeglitazone, in Human Plasma and Urine Using LC–MS/MS and Its Application to a Pharmacokinetic Study in CHROMATOGRAPHIA
  • 2012-02 Effect of Oseltamivir on Bleeding Risk Associated with Warfarin Therapy in CLINICAL DRUG INVESTIGATION
  • 2011-09-07 Prolonged Use of Aspirin Alters Human and Rat Intestinal Cells and Thereby Limits the Absorption of Clopidogrel in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2011-04-19 The use of healthy volunteers instead of patients to inform drug dosing studies: a [11C]raclopride PET study in PSYCHOPHARMACOLOGY
  • 2011-01-09 Simultaneous LC–MS–MS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study in CHROMATOGRAPHIA
  • 2009-12-18 Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects in MALARIA JOURNAL
  • 2007-08-08 Pharmacokinetic and Pharmacodynamic Interaction of Lorazepam and Valproic Acid in Relation to UGT2B7 Genetic Polymorphism in Healthy Subjects in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-12-27 Modeling of Brain D2 Receptor Occupancy‐Plasma Concentration Relationships with a Novel Antipsychotic, YKP1358, Using Serial PET Scans in Healthy Volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-12-05 Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2006-02-28 PIII‐3 in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-02-28 PIII‐18 in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2006-02-28 PII‐15 in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-10-05 Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-06-09 Effect of the UGT2B15 Genotype on the Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Intravenous Lorazepam in Healthy Volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-11-14 A variant 2677A allele of the MDR1 gene affects fexofenadine disposition in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-08-15 Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420204.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.254230.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.497743.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412484.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.50956.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411612.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Yu", 
        "givenName": "Kyung-Sang", 
        "id": "sg:person.012253717172.67", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-0921-7225"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012253717172.67", 
          "https://orcid.org/0000-0003-0921-7225"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_808.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.012253717172.67'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.012253717172.67'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.012253717172.67'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.012253717172.67'


     

    This table displays all metadata directly associated to this object as RDF triples.

    33 TRIPLES      11 PREDICATES      19 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.012253717172.67 schema:affiliation N99d7168067d345489c5f0934f2044d88
    2 grid-institutes:grid.254230.2
    3 grid-institutes:grid.411612.1
    4 grid-institutes:grid.412484.f
    5 grid-institutes:grid.420204.0
    6 grid-institutes:grid.497743.a
    7 grid-institutes:grid.50956.3f
    8 schema:familyName Yu
    9 schema:givenName Kyung-Sang
    10 schema:identifier N65eae6691f7647a0b2f21f3afd8dad37
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012253717172.67
    12 https://orcid.org/0000-0003-0921-7225
    13 schema:sdDatePublished 2022-11-24T21:37
    14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    15 schema:sdPublisher Nc3422108209b47c6a3463a6ab151f33c
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 N65eae6691f7647a0b2f21f3afd8dad37 schema:name orcid_id
    20 schema:value 0000-0003-0921-7225
    21 rdf:type schema:PropertyValue
    22 N99d7168067d345489c5f0934f2044d88 schema:affiliation grid-institutes:grid.31501.36
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 Nc3422108209b47c6a3463a6ab151f33c schema:name Springer Nature - SN SciGraph project
    26 rdf:type schema:Organization
    27 grid-institutes:grid.254230.2 schema:Organization
    28 grid-institutes:grid.31501.36 schema:Organization
    29 grid-institutes:grid.411612.1 schema:Organization
    30 grid-institutes:grid.412484.f schema:Organization
    31 grid-institutes:grid.420204.0 schema:Organization
    32 grid-institutes:grid.497743.a schema:Organization
    33 grid-institutes:grid.50956.3f schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...